S1N NEWS - to be effective in killing 100% of bird flu virus (H5N1) - 500 Beiträge pro Seite

[V51]

S1N

soeben


Sunwin International Neutraceuticals, Inc.: SUWN Announces its
Hypericin-Based Veterinary Disinfectant is Proven to
B: Sunwin International Neutraceuticals, Inc.: SUWN Announces its Hypericin-Base
Veterinary Disinfectant is Proven to be Effective in Killing Bird Flu Virus (H5
1) in an Independent Study ( M2 )

Qufu, China, Apr 04, 2007 (M2 PRESSWIRE via COMTEX) --
Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN),
a leader in the production and distribution of Chinese herbs,
veterinary medicines and low calorie sweetener (Stevia) in China,
announced today its Hypericin-based veterinary disinfectant has proven
to be effective in killing 100% of bird flu virus (H5N1) in research
tests involving H5N1-infected Chicken embryos. The research was
independently conducted by a group of scientists from Ha'erbing
Veterinary Institute of the Chinese Academy of Agricultural Sciences,
Animal Influenza Laboratory of the Ministry of Agriculture, and
National Bird Flu Reference Laboratory. Hypericin is a derivative of
St. Johns Wort.

The test results demonstrated that Sunwin's Hypericin-based veterinary
disinfectant eliminates 100% of bird flu virus (H5N1) in the infected
chicken embryos within 10 minutes when the Hypericin-based disinfectant
was diluted at ratios of 1:5, 1:10, 1:25 and 1:50. No significant
toxicities to healthy chicken embryos were observed when the
disinfectant was diluted at these same levels.

In November 2005, the Department of Livestock Farming for Shandong
Province Government submitted a fast-track application to the Livestock
Farming Bureau of China Ministry of Agriculture for approval of
Hypericin related products as a class one new veterinary medicine to
treat strands of the avian flu virus. This independent study was a
requirement of the approval process for the application.

Laiwang Zhang, President and Chairman of Sunwin International
Neutraceuticals, commented "We are extremely pleased with these
independent study results. We believe they validate the effectiveness
of Hypericin which will help pave the way for approval of our
Hypericin-based veterinary disinfectant as class one veterinary
medicine in China. If the use of this medicine is determined to be the
best way to prevent and deter the spread of bird flu virus by tens of
millions of poultry farmers in China, the economic impact on our
company could be enormous as we are one of only a few manufacturers of
these products in China."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) is engaged in
the areas of essential traditional Chinese medicine, low-calorie
natural sweetener (Stevia), and veterinary medicines and feeds prepared
from 100% organic herbal ingredients. As an industry leader in
agricultural processing, Sunwin has built an integrated global firm
with the sourcing and production capabilities to meet the needs of
consumers throughout the world. Sunwin also makes such value-added
products as specialty veterinary food ingredients and specialty feed
ingredients. The Sunwin family works closely with consumer to provide a
quality and a hybrid mix of agricultural products and services that
meet growing demand. For more info about Sunwin, please visit
http://www.sunwin.biz
Safe Harbor Statement

This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are based on current expectations or
beliefs, including, but not limited to, statements concerning the
Company's operations, financial performance and, condition. For this
purpose, statements that are not statements of historical fact may be
deemed to be forward-looking statements. The Company cautions that
these statements by their nature involve risks and uncertainties, and
actual results may differ materially depending on a variety of
important factors, including, but not limited to, the impact of
competitive products, pricing and new technology; changes in consumer
preferences and tastes; and effectiveness of marketing; changes in laws
and regulations; fluctuations in costs of production, and other factors
as those discussed in the Company's reports filed with the Securities
and Exchange Commission from time to time. In addition, the company
disclaims any obligation to update any forward-looking statements to
reflect events or circumstances after the date hereof.

CONTACT: Steven Silbert
Tel: [phone]
e-mail: [e-mail]

[V51]